Equity

Company Snapshot Home > Equity > Corporate Information > Company Snapshot

Divis Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:532488 NSE Symbol: DIVISLAB P/E (TTM) :76.14
ISIN Demat:INE361B01024 Div & Yield %:0.77 EPS (TTM) :51.38
Book Value (RS) :474.522963 Market Cap (Rs Cr.):103848.65 Face Value (RS) :2
    Change Company 
Stock Price Details Chart
Last Price (RS) 3,895.00 
Change (%) -16.90 (-0.43%) 
Best Buy (RS) 3889.95(x2) 
Best Sell (RS) 3899.15(x12) 
Today's Range (RS) 3,864.00 - 3,900.00 
52-Week Range (RS) 3,050.15 - 4,104.00 
Beta (1 Year) 0.62 
| | | |
Index Details
BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Shariah 50, bse carbonex
News Corporate Details
Divis Laboratories declare Quarterly Result
Divis Laboratories Ltd - Divis Laboratories Limited - Board Meeting
Divis Laboratories Ltd spurts 3.79%, up for five straight sessions
Divi's Laboratories plans capacity addition with investment of up to Rs 700 cr
Divis Laboratories Ltd - Divis Laboratories Limited - Updates
Divis Laboratories Ltd - Divis Laboratories Limited - Updates
Divis Laboratories Ltd - Divis Laboratories Limited - Other General Purpose
Divis Laboratories Ltd - Divis Laboratories Limited - Copy of Newspaper Publication
Divis Laboratories Ltd - Divis Laboratories Limited - Copy of Newspaper Publication
Divis Laboratories Ltd - Divis Laboratories Limited - Shareholders meeting
Incoporation Year :  1990
Chairman : Ramesh B V Nimmagadda
Ownership Group : Indian Private
Sector : MAN
Industry : Pharmaceuticals - Indian - Bulk Drugs
Registered Office
Divis Laboratories Ltd
1-72-23(P)/DIVIS/303 Divi Towe,
Cyber Hills Gachibowli,
Hyderabad,
Telangana-500032
Phone:91-40-23786300/23786352/400
Fax:91-40-23786460
E-Mail : mail@divislaboratories.com; cs@divislaboratories.c
URL : http://www.divislabs.com
Investor Returns
  Date Price Returns (%)
1Week 10-May-2024 3791.95 3.16
1Month 18-Apr-2024 3717.35 5.23
3Month 19-Feb-2024 3723.30 5.07
6Month 17-Nov-2023 3599.95 8.67
1Year 17-May-2023 3267.25 19.73
Mutual Funds Holding
Scheme Name % Holding Market Value (Rs Cr.)
SBI Equity Hybrid Fund 4.04 2761.66
SBI Focused Equity Fund 4.82 1600.96
AXIS ELSS Tax Saver Fund 3.21 1144.56
SBI Bluechip Fund 2.41 1093.34
SBI Nifty 50 ETF 0.51 920.42
Groups : Pharmaceuticals - Indian - Bulk Drugs
Company Last Price Change (%) 52Week High 52Week Low Market Cap (Rs Cr.)
Jubilant Pharmova Ltd 726.20 0.88 740.80 318.50 11,467.21
Neuland Laboratories Ltd 6,160.05 -1.52 7,794.00 2,603.20 8,024.90
Dishman Pharmaceuticals and Chemicals Ltd(Merged) 301.05 0.00 0.00 0.00 4,858.77
Ami Organics Ltd 1,249.10 -0.05 1,387.50 1,005.05 4,609.15
Aarti Drugs Ltd 492.65 0.54 645.00 430.00 4,504.82

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)